A New View on Biomarkers in Personalized and Systems Medicine for Metabolic Diseases

3,682 views

|

December 14, 2011

  • Share
  • Drugs in metabolic disease therapy are cheap and treatments are well established. Yet, current prevention and therapy does hardly account for the complexity and multifactorial character of the underlying processes. This has resulted in a therapy which is almost entirely focused on decreasing (symptomatic) risk factors, instead of targeting the underlying causal processes in a personalized manner, a surprisingly ineffective medical care!

    Flow Chemistry

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.